◆ 会议时间：2025年6月14-18日
◆ 会议地点：阿根廷 布宜诺斯艾利斯

◆ 会议简介：

2025年国际卫生技术评估协会(HTAi)年会将于2025年6月14-18日在阿根廷布宜诺斯艾利斯举行。

国际卫生技术评估协会(HTAi)是一个是全球性的、非营利性科学与专业学会，代表来自全球65个国家的82个组织和2500多名个人成员，他们是卫生技术评估研究人员、机构、政策制定者、消费者/患者、学术界和企业界人士。HTAi的任务是是通过提供一个中立的全球论坛，以交流信息、方法和专业知识，来支持HTA社区的发展，领域国际医学会议网译。HTAi主要借助循证医学、临床流行病学与卫生经济学宣等原理和方法，综合系统评价卫生技术的安全性、有效性、经济性、社会伦理和法律适应性等提出应用与否的建议，供决策者和机构参考。

HTAi每年定期在不同国家举办学术交流会议以促进全球HTA的发展。第一届HTAi年会于2003年在加拿大阿尔伯塔省坎莫尔举行，此后于每年的5月、6月或7月举行。HTAi年会汇集了来自世界各地的1,000多名研究人员、政策制定者、工业界、学术界、医疗服务提供者、机构和患者/消费者，是分享最新研究，推进政策和方法讨论以及围绕HTA建立全球网络的重要国际会议。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

HTAi 2025 - Health Technology Assessment international (HTAi) Annual Meeting

Date: June 14-18, 2025
Venue: Buenos Aires, Argentina

HTAi 2025 BUENOS AIRES
The HTAi 2025 Annual Meeting will take place June 14-18, 2025 in Buenos Aires, Argentina.

Global HTA stakeholders will convene to explore and shape the future of health technology assessment worldwide.

Discussions will centre around the theme, “NextGen Evidence: Diversifying and Advancing HTA to Meet Global Demands,” highlighting the evolving landscape and innovative approaches needed to address global health challenges.

Health Technology Assessment international (HTAi) is the global scientific and professional society for everyone who produces, uses, or encounters Health Technology Assessment to support optimal policy and decision making. Its mission is to support the growth of the HTA community by providing a neutral, global forum for the exchange of information, methods and expertise. With members from over 60 countries and across six continents, HTAi is a thriving global network. Our members regularly participate in Meetings, Policy Fora and Interest Groups. HTAi also provides access to a variety of resources including the International Journal of Technology Assessment in Health Care (IJTAHC). HTAi also supports national and regional initiatives for countries embarking on implementing HTA programs, and works to connect members with common interests.

摘要征文投稿：

Oral & Poster Abstracts:
Abstract submission opened September 25, 2024 and closed on December 5, 2024 at 23:59 Mountain Standard Time.
Oral & Poster Acceptance Notifications will be sent on January 30, 2025.

◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从事该领域研究的专家、科研人员、医药企业等。